Disease & disorder
rhabdomyosarcoma
MONDO:0005212
A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
6 shownIvonescimab in the Treatment of Multiple Advanced TumorsNCT06683846 · 2024-11-20
RECRUITINGFamilial Investigations of Childhood Cancer PredispositionNCT03050268 · 2017-04-06
RECRUITINGIndo-cyanine Green (ICG) in Paediatric Oncology MISNCT04854018 · 2021-04-30
COMPLETEDPRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineNCT05697198 · 2021-04-19
COMPLETEDVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)NCT03220035 · 2017-11-08
COMPLETEDStereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms TumorsNCT02581384 · 2017-01-01
TERMINATEDDrugs being studied
Research locations
BostonMassachusetts, United States2MemphisTennessee, United States2AlbanyNew York, United States1Ann ArborMichigan, United States1AshevilleNorth Carolina, United States1AtlantaGeorgia, United States1AuroraColorado, United States1AustinTexas, United States1BaltimoreMaryland, United States1BirminghamUnited Kingdom1BirminghamAlabama, United States1BoiseIdaho, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.